Chromatin remodelling is critical for repairing DNA damage and maintaining genomic integrity. Previous studies have reported that histone acetyltransferase p300 and ATP-dependent chromatin remodeler chromodomain helicase DNA-binding protein 4 (CHD4) functions, respectively, in DNA double-strand breaks (DSBs) repair. But the physiological significance of their interaction remains elusive. Here, we showed that p300 and CHD4 were both recruited to the sites of DSBs. Their ablation led to impaired DSBs repair and sensitised cells to laser and the anti-cancer drug, etoposide. Using DR-GFP and EJ5-GFP reporter systems, we found that knockdown of p300 or CHD4 impaired the homologous recombination (HR) repair but no the non-homologous end joining (NHEJ) repair. Furthermore, p300 or CHD4 knockdown respectively suppressed the recruitment of replication protein A (RPA), a key protein for HR, to the DSB sites. In addition, immunofluorescence results showed that knockdown of p300 reduced the recruitment of CHD4 at DSB sites. In turn, CHD4 knockdown also decreased p300 assembly. Moreover, immunoprecipitation and purified protein pull down assay revealed that p300 physically interacted with CHD4 at DNA damage sites, and this interaction was dependent on the chromodomain and ATPase/helicase domain of CHD4 and the CH2, Bd and HAT domains of p300. These results indicate that p300 and CHD4 could function cooperatively at DSB sites and provide a new insight into the detailed crosstalk among the chromatin remodelling proteins.
Introduction
DNA lesions trigger a signalling cascade that leads to the activation of cell-cycle checkpoints and DNA repair (1, 2) . DNA doublestrand break (DSB) is one of the lethal DNA damages which can be induced by a number of agents including ionizing radiation (IR), reactive chemical species and endogenous DNA processing byproducts (3) . DSBs must be repaired in order to maintain cellular viability and genomic stability. It is well known that chromatin remodelling is essential for the initiation, propagation and termination of DNA repair (4) .
In eukaryotic nuclei, enzymatic complexes can alter chromatin structure both by covalent modification and ATP-dependent chromatin remodelling (5, 6) . DNA damage-induced acetylation of core histones plays an important role in DSBs repair (7, 8) . In particular, the N-terminal lysine residues of histones H3 and H4 are acetylated during DSBs repair, which serve as binding sites for the recruitment of a number of downstream factors (7) (8) (9) . Recent studies have reported that the acetyltransferases p300 and Trrap-Tip60 in mammals facilitate DSBs repair by acetylating histones H3 and H4 (8, 10, 11) . Loss of p300 in human cells results in a defect in cell cycle checkpoint induced by stalled DNA replication (12) . Besides, the SWI2/SNF2 superfamily, one of the chromatin remodelling complexes, is recruited to DSB sites and promotes the nucleosomal position alterations (13) . Several studies have shown that INO80, SWR1 and RSC complexes are required for the recruitment of the repair proteins to DNA damage sites in yeast (14, 15) . Meanwhile, increasing body of evidence suggests that human chromodomain helicase DNA-binding protein 4 (CHD4) is required for normal IR sensitivity and is recruited in a dynamic manner to laser microirradiationinduced DSB tracks and/or IR-induced chromatin fractions (16) (17) (18) (19) . Furthermore, CHD4 could facilitate the recruitment of human MCPH1, BRCA1 and RNF8 to DNA damage sites (20, 21) , and CHD4-associated HDAC activity could influence the cell cycle progression due to the fact that NuRD deacetylates and destabilises p53 in human cells (17, 18) . Taken together, these studies suggest that histone acetylation and ATP-dependent chromatin remodelling cooperatively facilitate chromatin structure modulation and promote the recruitment of DNA repair proteins to DSB sites.
Though previous study has shown that histone acetylation by human p300 at DSB sites facilitates the recruitment of brahma (BRM), a catalytic subunit of the SWI/SNF complex (10), the concrete relationship between acetyltransferase and the ATP-dependent chromatin remodeler in response to DNA damage remains largely unknown. In this study, we showed that p300 affected the recruitment of CHD4 to DSB sites, while CHD4 ablation, in turn, decreased p300 assembly at DSBs sites. In addition, they were both required for the HR repair of DSBs and their depletion sensitised the cells to DNA damage agents. Furthermore, we identified p300 as a previously unknown binding partner of CHD4. Specifically, the chromodomain and ATPase/helicase domain of CHD4 and the CH2, Bd and HAT domains of p300 were responsible for their interaction. Collectively, these results reveal a novel crosstalk between the ATPdependent chromatin remodelling factor and acetyltransferase during DSBs repair. Inhibition of p300 or CHD4 activity may, therefore, be a way to sensitise cancer cells to radiotherapy and chemotherapy.
Materials and methods

Cell lines
HeLa and 293T cells were cultured in IMDM supplemented with 10% foetal bovine serum at 37°C with 5% CO 2 . DR-GFP-U2OS cells (gift from Dr. Yungui Yang, Beijing Institute of Genomics, Chinese Academy of Sciences) and EJ5-GFP-U2OS cells (gift from Dr. Xingzhi Xu, Capital Normal University) were cultured in DMEM supplemented with 10% foetal bovine serum.
Plasmids, siRNAs and reagents siRNA duplexes were obtained from Dharmacon (China). The specific siRNAs used were control siRNA (non-targeting), 5′-UUC UCC GAA CGU GUC ACG UTT-3′; p300 siRNA, AAC CCC UCC UCU UCA GCA CCA; CHD4 siRNA, 5′-GGU UUA AGC UCU UAG AAC A-3′; RAD51 siRNA, 5′-UGU AGC AUA UGC UCG AGC G-3′; Ku70 siRNA, 5′-GUC AGG GUG GGA GUC AUA UUA-3′; RNF8 siRNA, 5′-UGC GGA GUA UGA AUA UGA ATT-3′; PARP1 siRNA, 5′-CCA AAG GAA TTC CGA GAA A-3′. The shATM plasmid was provided by PhD Xi Shi (Northeast Normal University, China). pEGFP-CHD4, HA-wtCHD4, HA-D1, HA-D2, HA-D3 and HA-D4 plasmids were all kind gift of Dr. Guang Peng (University of Texas MD Anderson Cancer Center). GST-PP, GST-CC and GST-AH plasmids were constructed by subcloning fragments from pEGFP-CHD4 plasmid into the BamHⅠand EcoRⅠsites of pEGX-4T-2 vector. His-tagged domains of p300 were constructed by subcloning fragments from the coding sequences extracted from human HeLa cell into the HindIII and XhoI sites of pET-32a (+) vector. Primers used are shown in Supplementary Table 1 , available at Mutagenesis Online. The integrity of the constructs was verified by sequencing. Etoposide (ETO), MNase and Hoechst 33342 were purchased from Sigma Aldrich.
Transfections
Plasmid and siRNAs transfections were performed using Lipofectamine™ 2000 (Invitrogen) according to the manufacturer's instructions. Briefly, cells were plated in six-well plate as 30-40% confluent (2 ml medium per well), then transfected with indicated siRNAs. For individual transfection, the amount of siRNAs is 75 pmol/well and lipofectamine is 5 μl/well. Then the RNA/lipofectamine complex was dropped into the well and the cell were cultured for 6 h before changing for fresh medium. For double transfection, the amount of each siRNA is 75 pmol/well and lipofectamine is 10 μl/well. For plasmid transfection in six-well plate, the amount of plasmid is 2 μg/well and the lipofectamine is 6 μl/ well.
Antibodies
Rabbit polyclonal anti-CHD4 (sc-55606) and anti-p300 (sc-585) and mouse monoclonal anti-RNF8 (sc-271462) and anti-PARP1 (sc-74470) antibodies were from Santa Cruz Biotechnology (Dallas, TX); rabbit polyclonal anti-γH2AX (#9718S) antibody was from Cell Signalling Technology (Boston, MA); mouse monoclonal anti-γH2AX (05-636) and rabbit polyclonal anti-H2A (07-146) antibodies were from Millipore Corporation (CA); mouse monoclonal anti-β-actin (A5441), anti-GFP (G1546), anti-HA (H9658) and rabbit polyclonal anti-acetyl-Histone H3 (SAB4200328) antibodies were from Sigma-Aldrich; mouse monoclonal anti-RPA (ab2175) and rabbit polyclonal anti-RAD51 (ab63801) and anti-ATM (ab82512) antibodies were from Abcam (San Francisco); mouse monoclonal anti-His-tag (KM8001) antibody was from Sungene Biotech (Tianjin, China).
Cell colony formation assay
HeLa cells were transfected with indicated siRNAs and then plated in six-well dishes (1000 cells/dish). Cells were treated with indicated concentrations of ETO for 20 min and then changed for fresh medium. Meanwhile, mock control cells without siRNA and ETO treatment were seeded in every experiment to get the plating efficiency. Three independent experiments were performed and every sample was assayed in triplicate in every experiment. Following a 10-day recovery period, cells were fixed in 50% (v/v) methanol/0.01% (w/v) crystal violet solution for 5 min and washed twice with phosphate-buffered solution. The colonies containing 50 or more cells were scored as survivors (22) . The counted colony number of each sample was divided by 1000 to get the cloning efficiency. Survival points were calculated in each experiment as the mean cloning efficiency that was normalised to the plating efficiency of the mock control.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNAs were isolated by TRIzol reagent (Invitrogen) and 3 μg of total RNA was reverse transcribed using M-MLV Reverse Transcriptase (Promega). The following primer sequences were used for PCR: p300 sense: 5′-AAA CAA TCG AGC GGA ATA CTA CCA C-3′ and anti-sense: 5′-CCC TGT GAT GGG AAC TGA GTC TGA G-3′; CHD4 sense: 5′-CAC CGA ATC CTC AAC CA-3′ and antisense: 5′-GGC TGT CGC TCA TAC TT-3′; β-actin sense: 5′-CAC CAA CTG GGA CGA CAT-3′ and anti-sense: 5′-AGG CGT ACA GGG ATA GCA-3′. The PCR products were electrophoresed in 2% agarose gel.
Chromatin isolation
Approximately 4 × 10 6 cells were washed with phosphate-buffered solution and 10% cell pellets were lysed by RIPA (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 1% SDS, 1 mM EDTA, 1 mM Na3VO4, 2 mM NaF, 1 mM β-glycerophosphate, 2.5 mM sodium pyrophosphate) buffer containing 1 mM PMSF and protease inhibitors for whole cell lysate control. The 90% remaining cell pellets were resuspended in 200 μl of solution A (10 mM Hepes, pH 7.9, 10 mM KCl, 1.5 mM MgCl 2 , 0.34 M sucrose, 10% glycerol, 1 mM DTT, 10 mM NaF, 1 mM Na 2 VO 3 and protease inhibitors). Triton X-100 was added to a final concentration of 0.1%, and the cells were incubated for 10 min on ice. Cytoplasmic proteins were separated from nuclei by low-speed centrifugation (4 min at 1300×g, 4°C). The isolated nuclei were washed once with solution A and then lysed in 200 μl of solution B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT and protease inhibitors) for 30 min. Insoluble chromatin was collected by centrifugation (4 min at 1700 × g, 4°C), washed once in solution B and centrifuged again at high speed (10,000 × g) for 1 min. The final chromatin pellet was resuspended in 200 μl of Laemmli buffer and sonicated for 10 s. Chromatin was digested by resuspending in solution A containing 1 mM CaCl 2 and 50 units of MNase and incubating at 37°C for 1 min. Then the nuclease reaction was stopped by the addition of 1 mM EGTA (23) . The lysates were analysed by immunoblotting with indicated antibodies.
Laser microirradiation
HeLa cells were grown on coverslips and incubated in Hoechst 33342 (2 μg/ml) for 5 min as described before (24, 25) . Then cells were irradiated with pulsed nitrogen laser (50 Hz, 405 nm) at 85% output power, fixed with 10% (w/v) formaldehyde for 10 min and permeabilised with 0.5% (v/v) Triton X-100 for 5 min. The fixed cells were stained with indicated antibodies and DAPI. Images were taken using confocal microscope (FluoView FV1000, Olympus) integrated with a pulsed nitrogen laser (OLYMPUS, U-RFL-T).
Immunoprecipitation and western blotting
The cells were lysed with RIPA lysis buffer and the whole cell lysates were incubated with appropriate antibodies at 4°C for 3 h. Samples were then incubated for another 3 h with Protein A/G-Sepharose beads. After washing the samples with RIPA lysis buffer, the immunoprecipitates were resolved on SDS-PAGE and probed with antibodies as indicated.
Homologous recombination (HR) and nonhomologous end joining (NHEJ) repair analysis
HR and NHEJ were, respectively, measured in DR-GFP-U2OS and EJ5-GFP-U2OS cells according to previous publications (26) . DR-GFP-U2OS cells and EJ5-GFP-U2OS cells (1 × 10 5 per well) grown in six-well plates were pretransfected with indicated siR-NAs. Twenty-four hours later, cells were transfected with the I-SceI expression plasmid pCBASce, empty vector or pEGFP (2 μg/well). Forty-eight hours later, cells were harvested and analyzed for GFP positive cells by flow cytometry. For each analysis, 1 × 10 4 cells were collected, and each experiment was repeated three times. We then divided the number of every sample by the sample transfected with pEGFP to get the relative percentage of GFP positive cell.
Protein expression and GST pull-down assay
Escherichia coli strain BL-21 (DE3) was transformed with indicated plasmids and cultured overnight. GST-fusion protein expression was induced with IPTG. Cells were harvested in lysis buffer (20 mM Hepes (pH 7.5), 120 mM NaCl, 10% glycerol, 2 mM EDTA, 1 mg/ml lysozyme, 1 mM PMSF, 10 μg/ml each aprotinin and leupeptin) and homogenised by sonication. After centrifugation, GST-fusion proteins in supernatant were purified by glutathione-Sepharose 4B bead, according to the manufacturer's instructions (Amersham Pharmacia Biotech).
For GST pull-down assay, HeLa cells were lysed with RIPA lysis buffer. Cell lysates were incubated with 10 μl beads coated with GST or GST-fusion proteins for 2 h. The beads were collected by centrifugation and washed with ice-cold lysis buffer. After boiling in Laemmli sample buffer, the coimmunoprecipitated proteins were detected by immunoblotting.
Protein purification and PolyHis protein pulldown assay
GST-CC and GST-AH plasmids were transformed into BL21 and protein purification was performed as described in GST pull-down assay. Then the beads coated with GST-fusion protein were incubated in 50 mM Tris-HCl (pH > 8.0) with 100 mM KCl and 40 mM Glutathione and centrifuged for the supernate. The GST-fusion proteins were concentrated with column and incubated in dialysate (20 mM Tris-HCl (pH7.0), 4 mM EDTA). The total amount of prey GST-fusion protein per sample was 100 μg. His-tagged p300 mutants were purified and PolyHis protein pull-down assay was performed as described in Pierce TM Pull-Down PolyHis Protein:Protein Interaction Kit (Thermo Scientific).
Flow cytometry
DR-GFP cells were transfected with indicated siRNAs for 24 h. Then, cells were transfected with I-SceI plasmid and harvested by trypsinisation at indicated repair time intervals. Cells were fixed in 70% ethanol, and resuspended in 200 μl propidium iodide (PI) buffer (50 μg/ml) and RNase A (0.04 μg/ml) for 30 min at 37°C before analysis. Cell cycle analysis was performed by flow cytometry (FACSCalibur; BD). For each analysis, 1 × 10 4 cells were collected per sample, and the experiment was repeated three times. 
Statistical analysis
Results
p300 and CHD4 are crucial for DNA damage repair DNA damage occurs in the context of chromatin which is a barrier for the DNA repair proteins. Increasing studies have revealed that p300 plays a critical role in DNA damage repair (10, 11) and p300 coordinates with CHD4 in DSBs repair, 2016, Vol. 31, No. 2 CHD4 functions alone or as a subunit of NuRD complex during DSBs repair (17, 20, 21) . We first examined whether p300 and CHD4 depletion affects the clonogenic survival of HeLa cells treated with DSB-inducing agent. As shown in Figure 1A , either p300 or CHD4 knockdown decreased the viability of HeLa cells treated with topoisomerase inhibitor ETO at concentrations from 10 to 30 μM. Subsequently, we detected the dynamic of p300 and CHD4 at the DSB sites using laser microirradiation. The result showed that p300 and CHD4 were both recruited to laser microirradiated DSBs sites marked by γH2AX ( Figure 1B) . Moreover, chromatin fraction analysis verified that the recruitment of p300 and CHD4 to chromatin increased significantly in response to ETO-induced DSBs Figure 1 . p300 and CHD4 cooperates in DSBs repair. (A) HeLa cells were transfected with indicated siRNAs and exposed to ETO at the indicated doses. Ten days later, cells were stained with crystal violet. Colonies containing more than 50 cells were counted. Each value represents the mean ± SD. of three independent experiments. siCont, control siRNA. sip+C, p300 siRNA and CHD4 siRNA mixture. The expression of CHD4 and p300 were analysed by immunoblotting. (B) HeLa cells were laser microirradiated and allowed to repair for 1 h. The cells were then fixed and immunostained with anti-CHD4, anti-p300 and anti-γH2AX antibodies. Scale bar = 10 μm. (C) HeLa cells treated with 10 μM ETO for 20 min was allowed to repair for indicated time intervals. Then 10% of the cell pellets were lysed for whole cell lysate (WCL) and the remaining were extracted for chromatin fraction analysis. Protein samples were analysed by immunoblotting. (D, E) DR-GFP-U2OS cells and EJ5-GFP-U2OS cells were transfected with the indicated siRNAs for 24 h and then transfected with pCBASce, empty vector or GFP vector plasmids. After 48 h, cells were analyzed for GFP positive cells by FACS. The expression of HA-I-SceI was analysed by immunoblotting. siCont, control siRNA. sip+C, p300 siRNA and CHD4 siRNA mixture. **P < 0.01. (F) Cells were transfected with the indicated siRNAs and microirradiated with laser. One hour later, cells were fixed and immunostained with indicated antibodies. Scale bar = 10 μm. The expression of CHD4 and p300 were analysed by immunoblotting.
( Figure 1C ). These data suggest that p300 and CHD4 might be crucial effectors in response to DSBs repair.
As we all know, there are two major DSBs repair pathways: homologous recombination repair (HR) and non-homologous end-joining repair (NHEJ) (3, 27) . We then investigated which pathway is p300 and CHD4 mainly involved in by utilizing two classic I-SceI-mediated GFP reporter systems: DR-GFP-U2OS used to detect HR repair and EJ5-GFP-U2OS used to detect NHEJ repair. In DR-GFP-U2OS system, the DR-GFP reporter includes a GFP gene that contains an I-SceI endonuclease site within the coding region and an internal GFP repeat sequence with a mutant 3′ end. Expression of I-SceI induces a single DSB in the GFP gene. When the DSB is repaired by HR, GFP expression can be restored (20, 28, 29) . In EJ5-GFP-U2OS system, EJ5-GFP reporter consists of a GFP gene inserted with a Puromycine gene that is flanked by I-SceI recognition sites. Transient expression of I-SceI leads to DSB induction. NHEJ-mediated repair of the broken ends rendered the cells positive for GFP (25) . As shown in Figure 1D , either p300 or CHD4 knockdown resulted in a significant decrease of GFP positive DR-GFP-U2OS cells, which is comparable to the RAD51 knockdown, the key protein in HR. Moreover, a combined knockdown of p300 and CHD4 did not exhibit obviously additive inhibition on the HR repair efficiency. Previous study reported that CHD4 depletion results in G1 arrest. To exclude that the impaired HR repair resulted from the cell cycle arrest in CHD4 knockdown cells, we detected the cell cycle distribution in DR-GFP-U2OS cell Figure 2 . CHD4 interacts with p300 in response to DSBs. (A) HeLa cells treated with 10 μM ETO or not were lysed after repairing for 1 h and immunoprecipitated with CHD4 or p300 antibodies. The immunocomplex was analysed by immunoblotting. The quantification of relative p300 or CHD4 level was shown below. (B) HeLa cells were transfected with GFP-CHD4 and treated with 10 μM ETO for 20 min. One hour later, cells were fixed and immunostained with indicated antibodies. Immunofluoresence analysis of p300 and GFP-CHD4 was shown. Pearson's correlation coefficient was analysed by Image J software. Scale bar = 10 μm. **P < 0.01. (C) HeLa cells stably transfected with shControl or shATM plasmids were treated with 10 μM ETO or not and lysed after repairing for 1 h. Cell lysates were immunoprecipitated with CHD4 antibody. The immunocomplex was analysed by immunoblotting. shC or shCont, shControl plasmid. The expression of ATM was analysed by immunoblotting. p300 coordinates with CHD4 in DSBs repair, 2016, Vol. 31, No. 2 after CHD4 and/or p300 knockdown. We found that CHD4 and/or p300 knockdown moderately led to G1 accumulation, suggesting that the impaired HR repair is not due to the cell cycle arrest in G1 ( Supplementary Figure 1 , available at Mutagenesis Online). When detecting the NHEJ repair efficiency using EJ5-GFP-U2OS cell, we observed that neither CHD4 knockdown nor p300 knockdown had obvious effect on the proportion of NHEJ-mediated GFP-positive cells, while NHEJ key protein Ku70 depletion led to significant decrease of GFP-positive cells ( Figure 1E ). Additionally, immunofluorescence results showed that p300 or CHD4 knockdown both dramatically impaired the recruitment of the HR protein RPA to DSB sites, but only had moderately effect on the assembly of NHEJ protein Ku 70 ( Figure 1F and Supplementary Figure 2 , available at Mutagenesis Online). These data strongly indicate that p300 and CHD4 might play an important role in the HR repair pathway during DNA damage response. There are studies showing that p300 could associate with CHD4 in T cell development (30) . To investigate whether p300 interacts with CHD4 in response to DNA damage, we performed coimmunoprecipitation experiments. As shown in Figure 2A , p300 and CHD4 coexisted in the immunocomplex but not in control IgG immunoprecipitates, and the interaction increased after DSBs induction. Furthermore, immunofluorescence analysis showed that p300 were colocalised with GFP-CHD4 and the colocalisation increased after ETO-treatment ( Figure 2B) . In DSBs repair, CHD4 is phosphorylated by ATM (31) . Then, we examined whether the interaction between CHD4 and p300 is dependent on the phosphorylation of CHD4. HeLa cells were stably transfected with sh-control or sh-ATM plasmid and treated with ETO. The immunoprecipitation result showed that CHD4 still interacted with p300 when ATM was knockdown, suggesting that the phosphorylation of CHD4 is dispensable for its interaction with p300 ( Figure 2C ). The ATM interference efficiency is shown on the right. Taken together, our findings indicate that p300 interacts with CHD4 in response to DSBs repair. p300 regulates the recruitment of CHD4 to DNA damage sites A previous study indicated a link between chromatin remodelling complex SWI/SNF and p300 in DNA damage response (10) . Our results above also raise an interesting question about the functional significance of the relationship between p300 and CHD4. To answer this, we first examined the effects of p300 knockdown on the expression level of CHD4. In Figure 3A , we observed that both the protein level and the mRNA level of CHD4 remained unchanged in the p300 knockdown cells. Moreover, in turn, CHD4 knockdown did not affect the expression level of p300 ( Supplementary Figure 3 , available at Mutagenesis Online, the upper panel). Given that p300 is an acetyltransferase, we next tested whether the acetylation of CHD4 is regulated by p300. As shown in Figure 3B , p300 knockdown had little effect on the acetylation level of CHD4, indicating that CHD4 acetylation was not regulated by p300. Subsequently, by using IR-induced foci staining, we further explored whether p300 affects the recruitment of CHD4 to the DNA damage sites. In Figure 3C , we observed that p300 knockdown significantly reduced the recruitment of CHD4 at the DNA damage sites. Meanwhile, CHD4 knockdown also led to obvious decrease of p300 enrichment at DNA damage sites ( Figure 3D ). To further detect the recruitment of CHD4 and p300 at DSBs sites, we then purified the chromatin-enriched fraction to test the loading of CHD4 and p300 on the chromatin. As shown in Figure 3E , depletion of p300 resulted in a significant decrease of CHD4 assembly on chromatin after ETO treatment. In addition, the recruitment of p300 to chromatin in response to ETO-induced DNA damage was also reduced when CHD4 was knockdown ( Figure 3E ), which accordingly led to the decrease of H3 acetylation ( Supplementary Figure 3 , available at Mutagenesis Online, the lower panel). These data indicate that p300 regulates the recruitment of CHD4 at DNA damage sites, while the CHD4 recruitment in turn facilitates the assembly of p300.
It has been suggested that CHD4 could be recruited to DSBs sites by binding to poly (ADP-ribosyl)ated proteins, including PARP1 (poly(ADP-ribose) polymerase 1) (17) or via interaction with the ubiquitin ligase ring finger protein (RNF 8) (21) . We then explored whether p300 affects the association of CHD4 with Figure 4 . p300 regulates the interaction between CHD4 and RNF8. (A-C) HeLa cells were transfected with indicated siRNAs for 48 h. Then the cells were treated with ETO for 20 min and allowed to repair for 1 h. Cells were lysed and immunoprecipitated with CHD4 antibody. The immunocomplex was analysed by immunoblotting with indicated antibodies.
PARP-1 or RNF8 using immunoprecipitation assay. As shown in Figure 4A , p300 knockdown led to decrease of RNF8 level in CHD4 immunocomplex, but had little effect on the level of PARP1. Meanwhile, PARP1 knockdown blocked the interaction between p300 and CHD4, but not the interaction between RNF8 and CHD4 ( Figure 4B ). Interestingly, RNF8 knockdown did not have obvious effect on the level of p300 and PARP1 in CHD4 immunocomplex ( Figure 4C ). These data indicate that p300 might play an important role in CHD4 recruitment upstream of RNF8, while PARP1 might regulate the interaction between p300 and CHD4.
The interaction between p300 and CHD4 is dependent on the chromodomain and ATPase domain of CHD4
The above results demonstrated that p300 could interact with CHD4. We next explored which domain of CHD4 was responsible for this interaction. CHD4 contains two plant homeodomains (PHDs), two chromodomains, an ATPase/helicase domain and a putative C-terminal nuclear localisation signal (NLS) domain (17, 32) . The ATPase/helicase domain is necessary for the function of CHD4 in nucleosome remodelling via ATP hydrolysis (32) . We first generated a series of deletion mutants of CHD4 ( Figure 5A ) and performed co-immunoprecipitation assay. As shown in Figure 5B , the interaction between p300 and CHD4 was impaired when the ATPase/helicase domain of CHD4 was deleted (D3). However, the C-terminal mutation (D4) with ATPase/helicase domain was unable to pull down p300. This might be due to the fact that the mutant D4 without NLS could not be localised into the nucleus. In addition, the PHD and chromodomain mutant CHD4 (D2) exhibited reduced binding ability to p300, suggesting that the PHD and chromodomain might be also responsible for this interaction ( Figure 5B ). In order to verify the above finding in vitro, we fused the GST-tag to the PHD (PP), chromodomain (CC) and ATPase/helicase domain (AH) of CHD4 ( Figure 5C ) and performed GST pull-down assay. As shown in Figure 5D , the chromodomain (GST-CC) and ATPase/ helicase domain (GST-AH) of CHD4 exhibited high binding affinity with p300, while the PHD domains (GST-PP) could not be coimmunoprecipitated with p300. These data collectively suggest that the chromodomains and ATPase/helicase domain of CHD4 are responsible for its interaction with p300.
Next, we further investigated which domain of p300 could interact with the chromodomain and ATPase/helicase domain of CHD4. We fused His-tag to the 9 different domains of p300 ( Figure 6A ). Then, we purified the His-tagged p300 domains and GST-tagged CHD4 mutants (GST-CC and GST-AH) proteins to perform His pull-down assay. We observed that the CH2 and Bd domains of p300 could bind to the chromodomain (CC) of CHD4, while the CH3 and IBiD domains showed weak binding ability to GST-CC ( Figure 6B ). In addition, the HAT domain of p300 could bind to the ATPase/helicase domain (AH) of CHD4 ( Figure 6C ). Taken together, the results indicate that the ATPase domain and chromodomain of CHD4, and the CH2, HAT and Bd domains of p300 are responsible for their interaction.
Discussion
Recent studies have shown that p300 could be recruited to DSB sites, where it acetylates histones H3 and H4 (10, 11) . p300 also regulates the transcription of BRCA1 and RAD51 (33) . Meanwhile, the role of CHD4 in DNA damage response and genome maintenance has been highlighted (16) (17) (18) 31) . Since many different chromatin remodelling factors could be recruited to DNA damage sites, it is difficult to clearly define the contribution of these proteins to DNA damage repair. Previous studies had reported that p300 facilitate DSBs repair by acetylating histones H3 and H4 at DSB sites, which further promotes the recruitment of SWI/SNF complex to DSB sites (10) . In this study, we showed that p300 interacted with CHD4 and influenced the recruitment of CHD4 to DSB sites. In turn, the assembly of CHD4 further facilitated the assembly of p300 at DSBs sites. This crosstalk between p300 and CHD4 suggests that there is a sophisticated relationship among the chromatin remodelling factors in the DNA repair process.
CHD4 is a multi-functional protein and could interact with many factors in DNA damage repair process. However, the mechanism by which CHD4 is recruited to the DSBs sites is not very clear. Previous study showed that poly (ADP-ribosyl)ated proteins, including PARP1, regulates the recruitment of CHD4 to DSBs sites (17) . Additionally, the ubiquitin ligase RNF 8 could interact with CHD4 and promote its recruitment at DSBs sites (21) . Here, we found that p300 knockdown reduced the recruitment of CHD4 at DSB sites and impaired the interaction between CHD4 and RNF8, but did not affect the interaction between CHD4 and PARP1. The results indicated that p300 might be an upstream regulator of the interaction between CHD4 and RNF8. Furthermore, we observed that PARP1 knockdown led to significant decrease of p300 amount in CHD4 immunocomplex, suggesting PARP1 may facilitate the interaction between CHD4 and p300. However, we did not detect obvious effect of PARP1 knockdown on the interaction between CHD4 and RNF8. This result implied that there might be other factors besides p300, RNF8 and PARP1 involved in the regulation of CHD4 recruitment.
As we know, there are two major repair pathways for DSBs damage: HR repair and NHEJ repair (3, 27) . Studies from Ogiwara H showed that p300 contribute to the HR repair, by regulating the histone acetylation at promoter regions of HR-related genes and at DSB sites (33) . However, another study showed that p300 is required for the NHEJ repair by regulating the recruitment of Ku70/80 at DSB sites (10) . In this study, we found that p300 knockdown led to impaired RPA recruitment at DSB sites and impaired HR repair. When detecting the efficiency of NHEJ repair, we found that p300 depletion had no significant effect on the NHEJ repair. The inconsistent data obtained in different labs Figure 6 . CH2, Bd and HAT domains of p300 mediate its interaction with CHD4. (A) The diagram of p300 domains. CH1, TAZ1 domain. CH2, RING and PHD domain. CH3, ZZ and TAZ2 domain. Bd, bromodomain. (B, C) His-tagged p300 deletion mutants and GST-tagged CHD4 mutants (CC and AH domains) were purified from BL21. Then protein-protein interaction assay was performed according to Pierce TM pull-down PolyHis kit. Bound proteins were separated by SDS-PAGE and immunoblotted with GST and His antibodies. #, protein dimer. might result from the different assay systems and cell-lines used. In the present study, we reproduced HR repair using DR-GFP reporter system in U2OS cell and NHEJ repair using EJ5-GFP reporter system in U2OS cell, whereas in the study of Ogiwara H, they reproduced NHEJ repair using pIRES-TK-EGFP reporter system in H1299 cell. Thus, based on the findings above, we assumed that the major pathways involved in DSB repair are likely to be regulated by p300 in different ways.
When DSBs occur, a series of DNA damage responses is activated including cell cycle arrest (1, 2) . Previous studies had shown that treating cells with CHD4 siRNAs increased the proportion of G1 phase in the absence of DNA damage, while combined irradiation and CHD4 depletion led to pronounced G1 arrest (17, 18) . However, in Larsen's study, they found that treating cells with CHD4 siRNAs moderately reduced S and G2 compartments in unstressed cells, while combined irradiation and CHD4 depletion led to clearly G1 arrest (16) . In the present study, to exclude that the impaired HR repair resulted from the cell cycle arrest in CHD4 knockdown cells, we detected the cell cycle distribution after CHD4 knockdown. Based on the flow cytometry data, we found that CHD4 depletion did not lead to significant G1 arrest in DR-GFP-U2OS cells. The reasons why there are differences in the cell cycle profile induced by CHD4-depletion among the studies are not very clear.
Enhanced DSBs repair activity within cancer cells, which allows the cells to evade laser and anticancer drug induced cell death, is a problematic issue in cancer therapy. In this study, siRNA-mediated ablation of p300 or CHD4 increased the sensitivity of cancer cells to anti-cancer drug. Thus, the suppression of p300 or CHD4 activity might be a promising therapeutic method for sensitizing cancer cells to radiotherapy and chemotherapy.
